Fundraising Fox

Oleg Nodelman

Investor

Founder + Portfolio Manager at EcoR1 Capital

San Francisco, California, United States

FoundedAktis OncologyEpikastScorpion Therapeutics

About

Founder and Portfolio Manager of EcoR1 Capital with over twenty years of biotech investing experience; previously a portfolio manager at BVF Partners and currently a board member of several publicly traded biotech companies. Holds a BS in Foreign Service from Georgetown University.

Invests in

Biotech

Experience

  1. EcoR1 Capital, LLCFounder and Managing Directorcurrent2012 — presentSan Francisco Bay Area
  2. The Gladstone InstitutesPresident's Council2012 — 2015San Francisco Bay Area
  3. Kindred BioNon Executive Director2013 — 2014San Francisco Bay Area
  4. Addex PharmaceuticalsNon-Executive Director2011 — 2014Geneva, Geneva, Switzerland
  5. BVF Partners LPPortfolio Manager2001 — 2012San Francisco Bay Area
  6. Mercer Management ConsultingConsultant1999 — 2001San Francisco Bay Area
  7. Atlanta Olympic BroadcastingRussian Translator1996Atlanta Metropolitan Area

Education

  1. Georgetown UniversityBSFS, Foreign Service / Science and Technology1995 — 1999

Skills & more

Mergers & AcquisitionsDue DiligenceVenture CapitalBiotechnologyInvestmentsBusiness StrategyPortfolio ManagementValuationMergersBusiness DevelopmentInvestment BankingStart-ups
+12 moreHedge FundsExecutive ManagementPrivate EquityRisk ManagementCorporate DevelopmentFinancial AnalysisLife SciencesFinanceStrategyPharmaceutical IndustryManagementFinancial Modeling

Languages French · Russian · Spanish

From Oleg's professional profile.

Same school

Shared employers

Deals · 3

Aktis OncologyBoard seat

via EcoR1 Capital · filed Oct 2024 · $175M raise

Scorpion TherapeuticsBoard seat

via EcoR1 Capital · filed Jul 2024 · $150M raise

RECODE THERAPEUTICS, INC.Board seat

via EcoR1 Capital · filed Sep 2023 · $290M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at EcoR1 Capital